APA (7th ed.) Citation

E, A., PF, L., J, G., S, P., T, B., T, D., . . . P, V. d. A. (2001). Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Critical care medicine, 29(3), 503. https://doi.org/10.1097/00003246-200103000-00006

Chicago Style (17th ed.) Citation

E, Abraham, et al. "Lenercept (p55 Tumor Necrosis Factor Receptor Fusion Protein) in Severe Sepsis and Early Septic Shock: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Trial with 1,342 Patients." Critical Care Medicine 29, no. 3 (2001): 503. https://doi.org/10.1097/00003246-200103000-00006.

MLA (9th ed.) Citation

E, Abraham, et al. "Lenercept (p55 Tumor Necrosis Factor Receptor Fusion Protein) in Severe Sepsis and Early Septic Shock: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Trial with 1,342 Patients." Critical Care Medicine, vol. 29, no. 3, 2001, p. 503, https://doi.org/10.1097/00003246-200103000-00006.